FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099845488> ?p ?o ?g. }

• W2099845488 endingPage "34" @default.
• W2099845488 startingPage "28" @default.
• W2099845488 abstract "Using Northern blotting, the expression levels of the genes for polyamine metabolism regulatory proteins and clusterin have been measured in a series of 23 human prostate cancers (CaPs) dissected from radical prostatectomy specimens. Patient matched, nontumor tissue was dissected from benign areas of the gland. The results indicate that transcripts encoding ornithine decarboxylase (ODC), ODC antizyme, adenosylmethionine decarboxylase, and spermidine/spermine N1-acetyltransferase (SSAT) were significantly higher, whereas clusterin (sulfated glycoprotein 2) mRNA was significantly lower in tumors compared with the benign tissue. All mRNA levels were compared with those of histone H3 and growth arrest-specific gene 1, markers of cell proliferation and cell quiescence, respectively, and glyceraldehyde 3-phosphate dehydrogenase, a housekeeping gene. In poorly differentiated and locally invasive CaPs and in tumors with unfavorable prognosis or total prostate-specific antigen (PSA) levels > 10.0 ng/ml at diagnosis, an overall increase in the levels of H3 mRNA and a decrease in growth arrest-specific gene 1 mRNA was detected, indicative of higher proliferation activity, whereas the differences in expression levels for the polyamine metabolism and clusterin genes were higher. ODC and SSAT changes were positively correlated in normal tissue but not in high-grade cancer, whereas ODC antizyme and SSAT changes were positively correlated in more malignant CaPs but not in normal tissue. Tumor classification based on the changes in expression levels of all of the genes studied could be correlated to differentiation grade and local invasiveness classification systems in 72.2 and 83.3% of the cases, respectively. In a 1-year follow-up period, three patients whose CaPs ranked as less aggressive according to clinical staging, but classified as advanced cancers with the proposed molecular classification, showed increases in total PSA levels, indicative of tumor relapse. Thus, molecular classification, based on gene expression, may enhance the available prognostic tools for prostate tumors." @default.
• W2099845488 created "2016-06-24" @default.
• W2099845488 creator A5019760526 @default.
• W2099845488 creator A5046128752 @default.
• W2099845488 creator A5057238914 @default.
• W2099845488 creator A5060647802 @default.
• W2099845488 creator A5073188827 @default.
• W2099845488 creator A5074188047 @default.
• W2099845488 creator A5084682964 @default.
• W2099845488 date "2000-01-01" @default.
• W2099845488 modified "2023-10-18" @default.
• W2099845488 title "Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens." @default.
• W2099845488 cites W1611116113 @default.
• W2099845488 cites W189012360 @default.
• W2099845488 cites W1996945731 @default.
• W2099845488 cites W2015461092 @default.
• W2099845488 cites W2033493498 @default.
• W2099845488 cites W2053504500 @default.
• W2099845488 cites W2059433877 @default.
• W2099845488 cites W2071368489 @default.
• W2099845488 cites W2073670227 @default.
• W2099845488 cites W2073925881 @default.
• W2099845488 cites W2075990367 @default.
• W2099845488 cites W2078143431 @default.
• W2099845488 cites W2080086131 @default.
• W2099845488 cites W2089764384 @default.
• W2099845488 cites W2102278661 @default.
• W2099845488 cites W2116879291 @default.
• W2099845488 cites W2117794550 @default.
• W2099845488 cites W2124839428 @default.
• W2099845488 cites W2130594082 @default.
• W2099845488 cites W2131287825 @default.
• W2099845488 cites W2140501888 @default.
• W2099845488 cites W2161356660 @default.
• W2099845488 cites W2340073049 @default.
• W2099845488 cites W2409465083 @default.
• W2099845488 cites W2415712056 @default.
• W2099845488 cites W2903767924 @default.
• W2099845488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10646846" @default.
• W2099845488 hasPublicationYear "2000" @default.
• W2099845488 type Work @default.
• W2099845488 sameAs 2099845488 @default.
• W2099845488 citedByCount "49" @default.
• W2099845488 countsByYear W20998454882012 @default.
• W2099845488 countsByYear W20998454882015 @default.
• W2099845488 countsByYear W20998454882016 @default.
• W2099845488 countsByYear W20998454882017 @default.
• W2099845488 countsByYear W20998454882018 @default.
• W2099845488 countsByYear W20998454882019 @default.
• W2099845488 countsByYear W20998454882020 @default.
• W2099845488 countsByYear W20998454882021 @default.
• W2099845488 countsByYear W20998454882022 @default.
• W2099845488 crossrefType "journal-article" @default.
• W2099845488 hasAuthorship W2099845488A5019760526 @default.
• W2099845488 hasAuthorship W2099845488A5046128752 @default.
• W2099845488 hasAuthorship W2099845488A5057238914 @default.
• W2099845488 hasAuthorship W2099845488A5060647802 @default.
• W2099845488 hasAuthorship W2099845488A5073188827 @default.
• W2099845488 hasAuthorship W2099845488A5074188047 @default.
• W2099845488 hasAuthorship W2099845488A5084682964 @default.
• W2099845488 hasConcept C104317684 @default.
• W2099845488 hasConcept C121289238 @default.
• W2099845488 hasConcept C126322002 @default.
• W2099845488 hasConcept C134018914 @default.
• W2099845488 hasConcept C150194340 @default.
• W2099845488 hasConcept C153911025 @default.
• W2099845488 hasConcept C181199279 @default.
• W2099845488 hasConcept C190283241 @default.
• W2099845488 hasConcept C2776109719 @default.
• W2099845488 hasConcept C2777497464 @default.
• W2099845488 hasConcept C2779476363 @default.
• W2099845488 hasConcept C2780115381 @default.
• W2099845488 hasConcept C502942594 @default.
• W2099845488 hasConcept C55493867 @default.
• W2099845488 hasConcept C71924100 @default.
• W2099845488 hasConcept C86803240 @default.
• W2099845488 hasConceptScore W2099845488C104317684 @default.
• W2099845488 hasConceptScore W2099845488C121289238 @default.
• W2099845488 hasConceptScore W2099845488C126322002 @default.
• W2099845488 hasConceptScore W2099845488C134018914 @default.
• W2099845488 hasConceptScore W2099845488C150194340 @default.
• W2099845488 hasConceptScore W2099845488C153911025 @default.
• W2099845488 hasConceptScore W2099845488C181199279 @default.
• W2099845488 hasConceptScore W2099845488C190283241 @default.
• W2099845488 hasConceptScore W2099845488C2776109719 @default.
• W2099845488 hasConceptScore W2099845488C2777497464 @default.
• W2099845488 hasConceptScore W2099845488C2779476363 @default.
• W2099845488 hasConceptScore W2099845488C2780115381 @default.
• W2099845488 hasConceptScore W2099845488C502942594 @default.
• W2099845488 hasConceptScore W2099845488C55493867 @default.
• W2099845488 hasConceptScore W2099845488C71924100 @default.
• W2099845488 hasConceptScore W2099845488C86803240 @default.
• W2099845488 hasIssue "1" @default.
• W2099845488 hasLocation W20998454881 @default.
• W2099845488 hasOpenAccess W2099845488 @default.
• W2099845488 hasPrimaryLocation W20998454881 @default.
• W2099845488 hasRelatedWork W1723554443 @default.
• W2099845488 hasRelatedWork W1980124508 @default.

• next